Search Results - "Ruus, P."

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin by Kapitza, C., Forst, T., Coester, H.-V., Poitiers, F., Ruus, P., Hincelin-Méry, A.

“…ABSTRACT Aim Assess the pharmacodynamics of lixisenatide once daily (QD) versus liraglutide QD in type 2 diabetes insufficiently controlled on metformin…”
Get full text

Oral administration of rac-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial by Jacob, S, Ruus, P, Hermann, R, Tritschler, H.J, Maerker, E, Renn, W, Augustin, H.J, Dietze, G.J, Rett, K

“…α-lipoic acid (ALA), a naturally occuring compound and a radical scavenger was shown to enhance glucose transport and utilization in different experimental and…”
Get full text

Effects of age and sex on the disposition of retigabine by Hermann, Robert, Ferron, Geraldine M., Erb, Katharina, Knebel, Norbert, Ruus, Peter, Paul, Jeffrey, Richards, Lyette, Cnota, Hans‐Peter, Troy, Steven

“…Background The novel antiepileptic drug retigabine is the first selective M‐current potassium channel opener for KCNQ2/3 and KCNQ3/5 channels. Retigabine…”
Get full text

PO13 Caractéristiques pharmacodynamiques du lixisénatide en une prise quotidienne vs le liraglutide chez des patients ayant un diabète de type 2 (DT2) non équilibré sous metformine by Kapitza, C, Coester, H, Poitiers, F, Heumann, G, Ruus, P, Hincelin-Méry, A

“…Objectif Cette étude randomisée, ouverte, avec administration répétée pendant 4 semaines, a comparé la pharmacodynamie du lixisénatide (20 µg par jour) vs le…”
Get full text

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers by Hermann, R., Niebch, G., Borbe, H.O., Fieger-Büschges, H., Ruus, P., Nowak, H., Riethmüller-Winzen, H., Peukert, M., Blume, H.

“…The pharmacokinetics and the absolute bioavailability of the enantiomers of α-lipoic acid (α-LA) from different dosage forms have been studied for the first…”
Get full text

Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha-Lipoic Acid following Oral Administration in Healthy Volunteers by Teichert, Jens, Hermann, Robert, Ruus, Peter, Preiss, Rainer

“…R(+)‐alpha‐lipoic acid is a natural occurring compound that acts as an essential cofactor for certain dehydrogenase complexes. The redox couple alpha‐lipoic…”
Get full text

Pharmacokinetics of naftopidil, a novel anti-hypertensive drug, in patients with hepatic dysfunction by Farthing, M. J., Alstead, E. M., Abrams, S. M., Haug, G., Johnston, A., Hermann, R., Niebch, G., Ruus, P., Molz, K. H., Turner, P.

“…The pharmacokinetics of naftopidil, a novel alpha-1 adrenoceptor-blocking antihypertensive, were investigated in ten patients (9M/1F) with hepatic dysfunction…”
Get full text

Pharmacokinetics of Alpha-Lipoic Acid in Subjects With Severe Kidney Damage and End-Stage Renal Disease by Teichert, Jens, Tuemmers, Tina, Achenbach, Harald, Preiss, Christa, Hermann, Robert, Ruus, Peter, Preiss, Rainer

“…In an open‐label, parallel‐group study involving 16 patients (8 with severely reduced renal function, 8 with end‐stage renal disease needing hemodialysis), the…”
Get full text

Retigabine N-Glucuronidation and Its Potential Role in Enterohepatic Circulation by HILLER, A, NGUYEN, N, STRASSBURG, C. P, QING LI, JAINTA, H, PECHSTEIN, B, RUUS, P, ENGEL, J, TUKEY, R. H, KRONBACH, T

“…The metabolism of retigabine in humans and dogs is dominated by N -glucuronidation ( McNeilly et al., 1997 ), whereas in rats, a multitude of metabolites of…”
Get full text

Gastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomers by Hermann, Robert, Wildgrube, H.Jörg, Ruus, Peter, Niebch, Georg, Nowak, Horst, Gleiter, Christoph H.

“…The objective of this study was to determine the impact of prolonged gastric emptying in patients with insulin dependent diabetes mellitus (IDDM) on the…”
Get full text

Time factors in endoscopic studies. A survey in West Germany by Phillip, J, Sahl, R J, Ruus, P, Rösch, T, Classen, M

“…In order to obtain representative data for the orientation of personal requirements in endoscopic units, 650 hospitals in the FRG were asked to have an exact…”
Get more information

Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate by Hermann, R, Ruus, P, Schneider, E, de Mey, C

“…The present study was conducted to describe and compare the in vivo performance (systemic exposure), clinical and laboratory safety of a fixed combinational…”
Get more information

Temporal aspects of endoscopic methods by Phillip, J, Classen, M, Sahl, R J, Ruus, P

Get more information